Pancreatic Cancer Research

ResearcherWhitehead Institute for Biomedical ResearchActive in the last 2 years

Douglas E. Biancur

Matched on ORCID iD 0000-0001-8800-7124; OpenAlex author ID A5025162023; NIH RePORTER profile ID 15665250. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
2
Labs led
0
Collaborators
31
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 2 papers, 1 grant · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper, 1 grant · 2025: none · 2026: 3 papers

Papers 11

  1. Hepatocytes promote liver metastasis of pancreatic cancer by providing serine. Co-author DOI 10.1038/s41586-026-11051-z↗
  2. Iron overload suppresses LKB1 and induces IL36G anti-tumor immunity in PDAC metastasis. Co-author DOI 10.1126/sciadv.adz8681↗
  3. Autophagy Inhibition Reprograms the Tumor Microenvironment of Pancreatic Cancer to Promote Macrophage Phagocytosis of Tumor Cells. Co-author DOI 10.1158/0008-5472.can-25-2451↗
  4. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Co-author DOI 10.1038/s43018-023-00647-3↗
  5. NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur Cluster Proteins. Co-author DOI 10.1158/2159-8290.cd-22-0043↗
  6. Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer. Co-author DOI 10.1016/j.cmet.2020.10.018↗
  7. Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11. First author DOI 10.1073/pnas.2021475118↗
  8. Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer. First author DOI 10.1016/j.cell.2020.10.016↗
  9. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Co-author DOI 10.1038/s41586-020-2229-5↗
  10. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Co-author DOI 10.1016/j.bbcan.2018.04.011↗
  11. Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. Co-author DOI 10.1158/2159-8290.cd-17-0952↗

Grants 2

  1. Identifying Metabolic Vulnerabilities in Pancreatic Cancer K00CA245822↗
  2. Identifying Metabolic Vulnerabilities in Pancreatic Cancer F99CA245822↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alec C. Kimmelman · 10 shared papers, 2018–2026 · strength 1.62
  2. Elaine Y. Lin · 6 shared papers, 2018–2026 · strength 1.08
  3. Keisuke Yamamoto · 6 shared papers, 2020–2026 · strength 0.92
  4. Robert Singhung Banh · 5 shared papers, 2020–2026 · strength 0.68
  5. Joel Encarnación-Rosado · 3 shared papers, 2024–2026 · strength 0.68
  6. Peter Y. Yu · 2 shared papers, 2026 · strength 0.50
  7. Mohamad Assi · 2 shared papers, 2026 · strength 0.50
  8. Subhadip Mukhopadhyay · 3 shared papers, 2020–2026 · strength 0.49
  9. Andrew J. Aguirre · 3 shared papers, 2021–2026 · strength 0.47
  10. Richard Possemato · 2 shared papers, 2026 · strength 0.47
  11. Joseph Douglas Mancias · 4 shared papers, 2020–2022 · strength 0.45
  12. Seth J. Parker · 3 shared papers, 2020–2024 · strength 0.41
  13. Stephanie K. Dougan · 1 shared paper, 2026 · strength 0.26
  14. Dafna Bar‐Sagi · 1 shared paper, 2026 · strength 0.24
  15. Anthony M Sorrentino · 1 shared paper, 2026 · strength 0.24
  16. Koelina Ganguly · 1 shared paper, 2026 · strength 0.24
  17. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.24
  18. Paul M. Grandgenett · 1 shared paper, 2026 · strength 0.24
  19. Mitsuhiro Fujishiro · 1 shared paper, 2026 · strength 0.24
  20. João A. Paulo · 2 shared papers, 2020–2021 · strength 0.23
  21. Annan Yang · 2 shared papers, 2018–2022 · strength 0.19
  22. Diane M. Simeone · 1 shared paper, 2024 · strength 0.18
  23. Naiara Santana-Codina · 1 shared paper, 2022 · strength 0.12
  24. Jonathan Andrew Nowak · 1 shared paper, 2022 · strength 0.12
  25. Huamin Wang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.